Catalyst Wire Dossier Catalyst Wire Dossier

Enlicitide

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Enlicitide, covering 2024-11-29 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) [Phase 3]

See pricing